EBSAM
SNY icon

Eubel Brady & Suttman Asset Management’s Sanofi SNY Stock Holding History

Eubel Brady & Suttman Asset Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-177
Closed -$9K – 297
2021
Q2 		$9K Buy
+177
New +$9.24K ﹤0.01% 531

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Eubel Brady & Suttman Asset Management's SNY Position: Q3 2021 in Review

Eubel Brady & Suttman Asset Management sold out of Sanofi (SNY) in Q3 2021, closing a stake of 177 shares — an estimated $9K sold.

Eubel Brady & Suttman Asset Management first reported a position in SNY in Q2 2021 and held it in 1 quarter. The position peaked at $9K in Q2 2021. 576 funds tracked by Wall St. Rank hold SNY as of Q3 2021.

  • Eubel Brady & Suttman Asset Management reported no remaining Sanofi position as of Q3 2021 after selling out during the quarter.
  • Eubel Brady & Suttman Asset Management sold 177 Sanofi shares in Q3 2021, an estimated $9K.
  • Eubel Brady & Suttman Asset Management first reported a position in Sanofi in Q2 2021 and held it in 1 quarter.
  • Eubel Brady & Suttman Asset Management's Sanofi position peaked at $9K in Q2 2021.
  • 576 funds tracked by Wall St. Rank held Sanofi as of Q3 2021.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q3 2021, filed 5 Nov 2021.